Patients With Myelodysplastic Syndromes Benefit From Therapy With Amifostine Pentoxifylline and Ciprofloxacin With Dexamethasone.

Turken, OrhanOrhan, BetülÖztürk, AhmetEtiz, DurmuşYaylacı, MustafaUskent, Necdet2019-06-272019-06-27200100006-49710006-4971https://hdl.handle.net/20.500.12469/232[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessPatients With Myelodysplastic Syndromes Benefit From Therapy With Amifostine Pentoxifylline and Ciprofloxacin With Dexamethasone.Conference Object276B276B1198WOS:000172134201254Q1